Inventor · disambiguated record
Yiping Rong
Also filed as: RONG YIPING
6 granted patents·16 pending applications·8 citations·filing 2008–2023
74Inventor score
Files withHARBOUR BIOMED SHANGHAI CO LTD12NONA BIOSCIENCES SUZHOU CO LTD3UNIV CASE WESTERN RESERVE2B7 THERAPEUTICS INC1DISTELHORST CLARK1
Top patents by PatentIndex Score
22 records- 0173US8034779B2Inhibitors of BCL-2UNIV CASE WESTERN RESERVE·Filed 2008·Granted Oct 11, 2011·4 cites·13 claims
- 0268US8445441B2Inhibitors of BCL-2DISTELHORST CLARK W·Filed 2011·Granted May 21, 2013·3 cites·12 claims
- 0367US9657073B2Inhibitors of Bcl-2DISTELHORST CLARK·Filed 2011·Granted May 23, 2017·1 cites·11 claims
- 0458US2025326843A1Bispecific antibody combination and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0556US12240905B2Antibodies binding CTLA-4 and uses thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 0656US10058588B2Inhibitors of BCL-2UNIV CASE WESTERN RESERVE·Filed 2017·Granted Aug 28, 2018·0 cites·6 claims
- 0756US2025215100A1Antigen binding protein targeting cd40, and preparation therefor and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0856US2025136694A1Anti-b7-h4 antibody, and preparation method therefor and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0956US2025136696A1Anti-b7-h7 antibody or antigen-binding fragment thereof, and preparation method therefor and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 1056US2022340673A1Antibody targeting bcma, bispecific antibody, and use thereofHARBOUR BIOMED SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 1152US2025215089A1Antigen-binding protein targeting pd-l1 and cd40, preparation therefor, and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 1252US2023303698A1Multispecific binding protein of immune cell engager, preparation therefor and application thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1351US2022363781A1Anti-tslp antibody and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1450US2024269276A1Specific binding protein targeting pd-l1 and cd73HARBOUR BIOMED SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1549US2023235090A1Bispecific antibody and use thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1649US2025154268A1Antibody targeting cd25, and preparation method therefor and use thereofNONA BIOSCIENCES SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1748US11098122B2Antibodies binding CTLA-4 and uses thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2018·Granted Aug 24, 2021·0 cites·17 claims
- 1846US2022411513A1Anti-pd-l1 antigen binding protein and application thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
- 1946US2024228635A9Ccr8 antibody and application thereofB7 THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2044US2024067748A1Antibody capable of binding to trop2, and use thereofNONA BIOSCIENCES SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 2144US2023312722A1Anti-b7h4 antibody, and bispecific antibody and use thereofNONA BIOSCIENCES SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 2243US2023357425A1Anti-cd73 antibody and application thereofHARBOUR BIOMED SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yiping Rong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →